Glenmark Draws Complete Response Letter for Allergy Spray

By Sam | June 28, 2019

Glenmark Pharmaceuticals said it is “confident” that it can get its investigational allergy spray Ryaltris back on track after the FDA pulled the brakes on its application in the form of a complete response letter.
Source: Drug Industry Daily

Posted in Drug Industry Daily